cxcr4 mab (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
93
Structured Review
R&D Systems
cxcr4 mab
Cxcr4 Mab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 17 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cxcr4+apc/Human+CXCR4+APC-conjugated+Antibody/pm19231846__ja807921k_si_001-86-7-10
Average 93 stars, based on 17 article reviews
Cxcr4 Mab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 17 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cxcr4+apc/Human+CXCR4+APC-conjugated+Antibody/pm19231846__ja807921k_si_001-86-7-10
Average 93 stars, based on 17 article reviews
cxcr4 mab - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Staining:Article Title: Cytokine-induced reprogramming of human macrophages toward Alzheimer’s disease-relevant molecular and cellular phenotypes in vitro Article Snippet: .. Cells were pre-stained with the following dyes/antibodies: Live/Dead Fixable Violet Dead Cell Stain kit (Life Technologies, cat. L34955 ) to exclude dead cells, CD11b-FITC (BioLegend, cat. 101206) and one of the DAM markers CD11c-APC 1:100 (BioLegend, cat. 301614), CD63-APC 1:100 (BioLegend, cat. 353007), Article Title: Methods for making definitive endoderm using at least GDF-8 Article Snippet: .. FACS Analysis: Cells for FACS analysis were blocked in a 1:5 solution of 0.5% human gamma-globulin (Sigma; Cat# G-4386) in PBS (Invitrogen; Cat #14040-133): BD FACS staining buffer—BSA (BD; Cat #554657) for 15 minutes at 4° C. Cells were then stained with antibodies for CD9 PE (BD; Cat #555372), CD99 PE (Caltag; Cat # MHCD9904) and Article Title: Cytokine-induced reprogramming of human macrophages toward Alzheimer's disease-relevant molecular and cellular phenotypes in vitro. Article Snippet: .. Cells were pre-stained with the following dyes/antibodies: Live/Dead Fixable Violet Dead Cell Stain kit (Life Technologies, cat. L34955) to exclude dead cells, CD11b-FITC (BioLegend, cat. 101206) and one of the DAM markers CD11c-APC 1:100 (BioLegend, cat. 301614), CD63-APC 1:100 (BioLegend, cat. 353007), Article Title: Differentiation of pluripotent stem cells Article Snippet: .. FACS Analysis: Cells for FACS analysis were blocked in a 1:5 solution of 0.5% human gamma-globulin (Sigma; Cat #G-4386) in PBS (Invitrogen; Cat #14040-133): BD FACS staining buffer—BSA (BD; Cat #554657) for 15 minutes at 4° C. Cells were then stained with antibodies for CD9 PE (BD; Cat #555372), CD99 PE (Caltag; Cat #MHCD9904) and Article Title: Cytokine-induced reprogramming of human macrophages toward Alzheimer’s disease-relevant molecular and cellular phenotypes in vitro Article Snippet: .. Cells were pre-stained with the following dyes/antibodies: Live/Dead Fixable Violet Dead Cell Stain kit (Life Technologies, cat. L34955) to exclude dead cells, CD11b-FITC (BioLegend, cat. 101206) and one of the DAM markers CD11c-APC 1:100 (BioLegend, cat. 301614), CD63-APC 1:100 (BioLegend, cat. 353007), FACS:Article Title: Methods for making definitive endoderm using at least GDF-8 Article Snippet: .. FACS Analysis: Cells for FACS analysis were blocked in a 1:5 solution of 0.5% human gamma-globulin (Sigma; Cat# G-4386) in PBS (Invitrogen; Cat #14040-133): BD FACS staining buffer—BSA (BD; Cat #554657) for 15 minutes at 4° C. Cells were then stained with antibodies for CD9 PE (BD; Cat #555372), CD99 PE (Caltag; Cat # MHCD9904) and Article Title: Differentiation of pluripotent stem cells Article Snippet: .. FACS Analysis: Cells for FACS analysis were blocked in a 1:5 solution of 0.5% human gamma-globulin (Sigma; Cat #G-4386) in PBS (Invitrogen; Cat #14040-133): BD FACS staining buffer—BSA (BD; Cat #554657) for 15 minutes at 4° C. Cells were then stained with antibodies for CD9 PE (BD; Cat #555372), CD99 PE (Caltag; Cat #MHCD9904) and Incubation:Article Title: Cancer-Associated Fibroblasts in Mycosis Fungoides Promote Tumor Cell Migration and Drug Resistance through CXCL12/CXCR4. Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. |